147 related articles for article (PubMed ID: 38015194)
1. The anti-inflammatory and vasoprotective properties of mPGES-1 inhibition offer promising therapeutic potential.
Steinmetz-Späh J; Jakobsson PJ
Expert Opin Ther Targets; 2023; 27(11):1115-1123. PubMed ID: 38015194
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of microsomal prostaglandin E-synthase-1 (mPGES-1) selectively suppresses PGE
Martin EM; Jones SL
Vet Immunol Immunopathol; 2017 Oct; 192():33-40. PubMed ID: 29042013
[TBL] [Abstract][Full Text] [Related]
3. Microsomal prostaglandin E synthase-1 inhibition promotes shunting in arachidonic acid metabolism during inflammatory responses in vitro.
Liu J; Peng B; Steinmetz-Späh J; Idborg H; Korotkova M; Jakobsson PJ
Prostaglandins Other Lipid Mediat; 2023 Aug; 167():106738. PubMed ID: 37094780
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of microsomal PGE synthase-1 reduces human vascular tone by increasing PGI
Ozen G; Gomez I; Daci A; Deschildre C; Boubaya L; Teskin O; Uydeş-Doğan BS; Jakobsson PJ; Longrois D; Topal G; Norel X
Br J Pharmacol; 2017 Nov; 174(22):4087-4098. PubMed ID: 28675448
[TBL] [Abstract][Full Text] [Related]
5. Identification of the two-phase mechanism of arachidonic acid regulating inflammatory prostaglandin E2 biosynthesis by targeting COX-2 and mPGES-1.
Akasaka H; Ruan KH
Arch Biochem Biophys; 2016 Aug; 603():29-37. PubMed ID: 27177970
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic definition of the cardiovascular mPGES-1/COX-2/ADMA axis.
Kirkby NS; Raouf J; Ahmetaj-Shala B; Liu B; Mazi SI; Edin ML; Chambers MG; Korotkova M; Wang X; Wahli W; Zeldin DC; Nüsing R; Zhou Y; Jakobsson PJ; Mitchell JA
Cardiovasc Res; 2020 Oct; 116(12):1972-1980. PubMed ID: 31688905
[TBL] [Abstract][Full Text] [Related]
7. Microsomal prostaglandin E
Zhang YY; Yao YD; Luo JF; Liu ZQ; Huang YM; Wu FC; Sun QH; Liu JX; Zhou H
Pharmacol Res; 2022 Jan; 175():105977. PubMed ID: 34798265
[TBL] [Abstract][Full Text] [Related]
8. Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders.
Koeberle A; Werz O
Biochem Pharmacol; 2015 Nov; 98(1):1-15. PubMed ID: 26123522
[TBL] [Abstract][Full Text] [Related]
9. A review on mPGES-1 inhibitors: From preclinical studies to clinical applications.
Bergqvist F; Morgenstern R; Jakobsson PJ
Prostaglandins Other Lipid Mediat; 2020 Apr; 147():106383. PubMed ID: 31698145
[TBL] [Abstract][Full Text] [Related]
10. Microsomal prostaglandin E
Psarra A; Nikolaou A; Kokotou MG; Limnios D; Kokotos G
Expert Opin Ther Pat; 2017 Sep; 27(9):1047-1059. PubMed ID: 28627961
[TBL] [Abstract][Full Text] [Related]
11. Protective Role of mPGES-1 (Microsomal Prostaglandin E Synthase-1)-Derived PGE
Hao H; Hu S; Wan Q; Xu C; Chen H; Zhu L; Xu Z; Meng J; Breyer RM; Li N; Liu DP; FitzGerald GA; Wang M
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1115-1124. PubMed ID: 29599139
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of GSK-3 reduces prostaglandin E2 production by decreasing the expression levels of COX-2 and mPGES-1 in monocyte/macrophage lineage cells.
Noma T; Takahashi-Yanaga F; Arioka M; Mori Y; Sasaguri T
Biochem Pharmacol; 2016 Sep; 116():120-9. PubMed ID: 27453433
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of microsomal prostaglandin E2 synthase-1 enzyme as emerging anti-inflammatory candidates.
Bahia MS; Katare YK; Silakari O; Vyas B; Silakari P
Med Res Rev; 2014 Jul; 34(4):825-55. PubMed ID: 25019142
[TBL] [Abstract][Full Text] [Related]
14. Cyclo-oxygenase-2 contributes to constitutive prostanoid production in rat kidney and brain.
Hétu PO; Riendeau D
Biochem J; 2005 Nov; 391(Pt 3):561-6. PubMed ID: 16008526
[TBL] [Abstract][Full Text] [Related]
15. Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease.
Wang M; Song WL; Cheng Y; Fitzgerald GA
J Intern Med; 2008 May; 263(5):500-5. PubMed ID: 18410593
[TBL] [Abstract][Full Text] [Related]
16. Deletion of microsomal prostaglandin E2 (PGE2) synthase-1 reduces inducible and basal PGE2 production and alters the gastric prostanoid profile.
Boulet L; Ouellet M; Bateman KP; Ethier D; Percival MD; Riendeau D; Mancini JA; Méthot N
J Biol Chem; 2004 May; 279(22):23229-37. PubMed ID: 15016822
[TBL] [Abstract][Full Text] [Related]
17. Necrosis in DU145 prostate cancer spheroids induces COX-2/mPGES-1-derived PGE2 to promote tumor growth and to inhibit T cell activation.
Sha W; Olesch C; Hanaka H; Rådmark O; Weigert A; Brüne B
Int J Cancer; 2013 Oct; 133(7):1578-88. PubMed ID: 23536473
[TBL] [Abstract][Full Text] [Related]
18. Nardosinanone N suppresses LPS-induced macrophage activation by modulating the Nrf2 pathway and mPGES-1.
Lio CK; Luo JF; Shen XY; Dai Y; Machado J; Xie Y; Yao YD; Yu Y; Liu JX; Yao XS; Luo P; Zhou H
Biochem Pharmacol; 2020 Mar; 173():113639. PubMed ID: 31536727
[TBL] [Abstract][Full Text] [Related]
19. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
20. [Research advances of prostaglandin E
Liu M; Guo MN; Chen LH
Sheng Li Xue Bao; 2021 Aug; 73(4):665-680. PubMed ID: 34405222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
